医学
不利影响
免疫系统
免疫疗法
重症监护医学
广谱
流行病学
癌症免疫疗法
肿瘤科
生物信息学
免疫学
内科学
组合化学
生物
化学
作者
Cynthia Connolly,Kalindi Bambhania,Jarushka Naidoo
标识
DOI:10.3389/fonc.2019.00530
摘要
Immunotherapy has heralded the advent of a new era in oncology. Immune checkpoint inhibitors (ICIs) enhance anti-tumor immunity, thereby reinvigorating a patient's immune system to fight cancer. While therapy with this class of agents has resulted in improved clinical outcomes for patients with multiple tumor types, a broad spectrum of immune-related adverse events (irAEs) may affect any organ system, with variable clinical presentations. Prompt recognition and management of irAEs are associated with improved irAE outcomes, and represents an important new clinical challenge for practicing oncologists. Herein, we provide a comprehensive case-based review of the most common and clinically-important irAEs, focussing on epidemiology, clinical manifestations, and management. We also examine future strategies that may provide meaningful insights into the prevention and management of irAEs.
科研通智能强力驱动
Strongly Powered by AbleSci AI